|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/21/2024 |
$23.39 |
$23.63 |
$22.83 |
$22.88 |
1.45M | 03/22/2024 |
$22.81 |
$22.98 |
$22.49 |
$22.58 |
1.08M | 03/25/2024 |
$22.58 |
$22.79 |
$22.40 |
$22.44 |
825.50K | 03/26/2024 |
$22.67 |
$22.96 |
$21.42 |
$21.44 |
1.25M | 03/27/2024 |
$21.79 |
$23.25 |
$21.69 |
$23.07 |
1.19M |
|
Syndax Pharmaceuticals is a clinical-stage biopharmaceutical company developing a pipeline of cancer therapies. Co.'s two primary product candidates are, revumenib (SNDX-5613), and axatilimab (SNDX-6352). Co. is developing SNDX-5613, a small molecule inhibitor of the menin-MLL binding interaction for the treatment of KMT2A rearranged, also known as mixed lineage leukemia rearranged, acute leukemias including acute lymphoblastic leukemia, and acute myeloid leukemia, or AML, and NPM1 mutant AML. Co. is also developing SNDX-6352, a monoclonal antibody that blocks the colony stimulating factor 1, in chronic graft-versus-host disease, as well as idiopathic pulmonary fibrosis. | |
|
Syndax Pharmaceuticals (SNDX) has the following price history information. Looking back at SNDX historical stock prices for the last five trading days, on March 21, 2024, SNDX opened at $23.39, traded as high as $23.63 and as low as $22.83, and closed at $22.88. Trading volume was a total of 1.45M shares. On March 22, 2024, SNDX opened at $22.81, traded as high as $22.98 and as low as $22.49, and closed at $22.58. Trading volume was a total of 1.08M shares. On March 25, 2024, SNDX opened at $22.58, traded as high as $22.79 and as low as $22.40, and closed at $22.44. Trading volume was a total of 825.50K shares. On March 26, 2024, SNDX opened at $22.67, traded as high as $22.96 and as low as $21.42, and closed at $21.44. Trading volume was a total of 1.25M shares. On March 27, 2024, SNDX opened at $21.79, traded as high as $23.25 and as low as $21.69, and closed at $23.07. Trading volume was a total of 1.19M shares.
SNDX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Syndax Pharmaceuticals shares, starting with a $10,000 purchase of SNDX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/03/2016 |
|
End date: |
03/27/2024 |
|
Start price/share: |
$12.01 |
|
End price/share: |
$23.07 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
92.09% |
|
Average Annual Total Return: |
8.43% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$19,213.35 |
|
Years: |
8.07 |
|
|
|
Date |
Close |
03/21/2024 | $22.88 | 03/22/2024 | $22.58 | 03/25/2024 | $22.44 | 03/26/2024 | $21.44 | 03/27/2024 | $23.07 |
|
|